Mesa Laboratories, Inc.
MLAB
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Společnost Mesa Laboratories, Inc. vyvíjí, vyrábí a prodává nástroje pro biologickou vědu a produkty a služby řízení kvality ve Spojených státech, Evropě, Asii a Tichomoří a v mezinárodním měřítku. Segment Sterilizace a dezinfekce společnosti vyrábí a prodává biologické, čisticí a chemické ukazatele, které se používají k posouzení účinnosti sterilizačních a dezinfekčních procesů v nemocničním, zubním, lékařském a farmaceutickém průmyslu. Tento segment také poskytuje testovací a laboratorní služby především pro zubní průmysl. Jeho segment Biopharmaceutical Development vyvíjí, vyrábí a prodává automatizované systémy pro analýzu bílkovin (imunoanalýzy) a řešení syntézy peptidů. Řešení tohoto segmentu zahrnují analýzu bílkovin zahrnující analytická zařízení, CD, sady a pufry; a syntetizátory peptidů, které umožňují automatizovat chemicky syntetizované peptidy, které se používají při vytváření peptidových terapií, biomateriálů, kosmetiky a obecného výzkumu. Segment společnosti Calibration Solutions navrhuje, vyrábí a prodává produkty pro kontrolu a kalibraci kvality pro měření nebo kalibraci teploty, tlaku, pH, vlhkosti a dalších takových parametrů používaných pro zdravotní a bezpečnostní účely v nemocnici, výrobě zdravotnických prostředků, výrobě farmaceutických výrobků a různých laboratorních a zdravotnických prostředích. Produkty tohoto segmentu zahrnují kontinuální monitorovací systémy, dialyzátory a spotřební materiál, záznamníky dat, kalibrační zařízení plynového toku a zařízení pro odběr vzorků vzduchu a systémy pro testování točivého momentu. Jeho segment klinické genomiky vyvíjí, vyrábí a prodává nástroje genetické analýzy, které zahrnují systém MassARRAY a spotřební materiál, včetně čipů, panelů a roztoků chemických činidel používaných klinickými laboratořemi k provádění genomických klinických testů v několika terapeutických oblastech, jako jsou screeningy novorozenců, farmakogenetika a onkologie. Společnost byla založena v roce 1982 a sídlí v Lakewoodu v Coloradu.
Sektor
Technology
Odvětví
Hardware, Equipment & Parts
Počet zaměstnanců
736
Založení
1984-02-29
Podobné společnosti
$ 1.05
- $ 0.03
$ 33.45
+ $ 0.49
$ 59.23
+ $ 0.25
$ 7.54
+ $ 0.14
$ 14.94
+ $ 0.52
$ 22.53
+ $ 1.10
$ 14.02
- $ 0.16
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 247.5 | 241.0 | 216.2 | 219.1 | 184.3 | 133.9 | 117.7 | 103.1 | 96.2 | 93.7 | 84.7 | 71.3 | 52.7 | 46.4 | 39.6 | 32.8 | 21.9 | |
| Cost of Revenues | 97.5 | 90.1 | 82.9 | 85.4 | 75.2 | 46.9 | 52.8 | 42.2 | 41.6 | 40.4 | 33.2 | 27.9 | 21.0 | 17.6 | 16.1 | 13.3 | 8.7 | |
| Gross Profit | 150.0 | 150.9 | 133.3 | 133.7 | 109.1 | 87.0 | 64.9 | 60.9 | 54.6 | 53.2 | 51.4 | 43.4 | 31.7 | 28.9 | 23.5 | 19.6 | 13.2 |
| Revenue | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 65.1 | 60.7 | 59.5 | 62.1 | 62.8 | 57.8 | 58.2 | 58.9 | 53.5 | 53.2 | |
| Cost of Revenues | 23.3 | 23.4 | 27.0 | 23.7 | 23.1 | 22.4 | 20.9 | 22.3 | 20.1 | 21.1 | |
| Gross Profit | 41.8 | 37.3 | 32.5 | 38.4 | 39.8 | 35.5 | 37.2 | 36.6 | 33.4 | 32.1 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 20.5 | 15.8 | 10.4 | 6.4 | 3.5 | 3.5 | 4.2 | 4.0 | 3.3 | 2.3 | 2.0 | 1.4 | 1.4 | 0.7 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 109.9 | 88.6 | 64.2 | 50.7 | 39.6 | 35.1 | 32.8 | 31.1 | 24.2 | 17.6 | 13.7 | 9.3 | 8.3 | 5.2 | |
| Depreciation & Amortization | 19.3 | 24.5 | 31.6 | 33.1 | 25.1 | 17.7 | 13.0 | 9.4 | 9.5 | 8.7 | 7.2 | 5.7 | 3.8 | 3.4 | 2.2 | 1.8 | 0.8 | |
| Total Operating Expenses | 132.8 | 134.5 | 405.3 | 130.4 | 104.4 | 74.7 | 57.1 | 43.1 | 38.6 | 36.9 | 35.1 | 27.5 | 19.9 | 15.8 | 10.7 | 9.7 | 5.8 | |
| Operating Income | 17.2 | 16.3 | -272.1 | -30.5 | -20.4 | -5.3 | -4.9 | 9.8 | 2.2 | 16.3 | 16.3 | 15.9 | 11.8 | 13.1 | 12.5 | 9.9 | 7.4 |
| Operating Income | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Depreciation & Amortization | 0.0 | 5.8 | 6.0 | 7.5 | 5.5 | 6.1 | 5.5 | 6.3 | 9.0 | 8.1 | ||
| Total Operating Expenses | 33.8 | 32.6 | 29.4 | 36.9 | 34.0 | 31.9 | 31.7 | 307.8 | 33.5 | 32.2 | ||
| Operating Income | 8.0 | 4.7 | 3.1 | 1.5 | 5.8 | 3.5 | 5.6 | -271.3 | -0.1 | -0.1 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 4.8 | 0.0 | 0.1 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 10.6 | 11.9 | 5.7 | 3.7 | 3.9 | 8.0 | 5.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -3.2 | -10.4 | -3.6 | -3.7 | 23.9 | 7.6 | 8.3 | -9.2 | -15.7 | -2.0 | -0.8 | -0.5 | 1.3 | -0.1 | -0.5 | -0.1 | 0.0 | |
| IBT | 14.1 | 6.0 | -275.6 | -0.4 | 3.6 | 2.3 | 3.4 | 8.6 | 0.3 | 14.3 | 15.6 | 15.3 | 13.1 | 13.0 | 12.3 | 9.8 | 7.4 | |
| Income Tax Expense | 10.3 | 7.9 | -21.4 | -1.3 | 1.7 | -1.0 | 2.1 | 1.1 | 3.3 | 3.1 | 4.4 | 5.8 | 4.1 | 4.5 | 4.4 | 3.6 | 2.6 | |
| Net Income | 3.7 | -2.0 | -254.2 | 0.9 | 1.9 | 3.3 | 1.3 | 7.5 | -3.0 | 11.2 | 11.2 | 9.6 | 9.0 | 8.5 | 7.9 | 6.2 | 4.8 |
| Net Income | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Interest Expense | 3.0 | 2.9 | 2.2 | 2.5 | 2.8 | 3.0 | 2.8 | 1.9 | 1.9 | 0.9 | ||
| Other Expense | -3.4 | -2.7 | 3.9 | -1.0 | -8.0 | 0.3 | -1.7 | -4.0 | 2.0 | -1.3 | ||
| IBT | 4.6 | 2.0 | 7.0 | 0.5 | -2.2 | 3.8 | 3.9 | -275.3 | 1.9 | -1.3 | ||
| Income Tax Expense | 1.0 | -0.5 | 2.3 | 7.6 | -0.5 | 0.4 | 0.5 | -20.7 | -0.2 | -0.1 | ||
| Net Income | 3.6 | 2.5 | 4.7 | -7.1 | -1.7 | 3.4 | 3.4 | -254.6 | 2.1 | -1.2 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.17 | $0.36 | $0.66 | $0.42 | $1.95 | $-0.79 | $3.04 | $3.10 | $2.72 | $2.61 | $2.52 | $2.41 | $1.91 | $1.49 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.17 | $0.35 | $0.64 | $0.41 | $1.86 | $-0.79 | $2.91 | $2.97 | $2.63 | $2.49 | $2.35 | $2.29 | $1.86 | $1.45 | |
| Shares Outstanding | 5.5 | 5.4 | 5.4 | 5.3 | 5.2 | 5.0 | 4.2 | 3.8 | 3.8 | 3.7 | 3.6 | 3.5 | 3.4 | 3.4 | 3.3 | 3.2 | 3.2 | |
| Diluted Shares Outstanding | 5.6 | 5.4 | 5.4 | 5.4 | 5.3 | 5.1 | 4.4 | 4.0 | 3.8 | 3.8 | 3.8 | 3.7 | 3.6 | 3.6 | 3.5 | 3.3 | 3.3 |
| Per Share Data | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Shares Outstanding | 5.5 | 5.5 | 5.5 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 | ||
| Diluted Shares Outstanding | 5.6 | 5.5 | 5.6 | 5.4 | 5.4 | 5.5 | 5.4 | 5.4 | 5.4 | 5.4 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 28.2 | 27.3 | 28.2 | 32.9 | 49.3 | 263.9 | 81.4 | 10.2 | 5.5 | 5.8 | 5.7 | 2.0 | 5.6 | 4.0 | 7.2 | 3.5 | 10.5 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 28.2 | 27.3 | 28.2 | 32.9 | 49.3 | 263.9 | 81.4 | 10.2 | 5.5 | 5.8 | 5.7 | 2.0 | 5.6 | 4.0 | 7.2 | 3.5 | 10.5 | |
| Accounts Receivable | 39.1 | 42.0 | 39.1 | 42.6 | 41.2 | 23.8 | 21.1 | 12.5 | 14.3 | 14.3 | 15.3 | 12.1 | 9.3 | 8.5 | 6.5 | 7.0 | 4.4 | |
| Inventory | 32.7 | 25.4 | 32.7 | 34.6 | 24.6 | 11.2 | 14.2 | 6.8 | 9.2 | 13.9 | 14.0 | 12.4 | 7.8 | 5.6 | 4.4 | 5.7 | 4.8 | |
| Other Current Assets | 9.4 | 8.0 | 9.4 | 8.9 | 75.0 | 39.1 | 41.4 | 1.6 | 26.5 | 30.0 | 31.5 | 27.6 | 21.0 | 15.4 | 1.0 | 1.0 | 0.8 | |
| Total Current Assets | 109.4 | 102.7 | 109.4 | 119.0 | 124.3 | 303.0 | 122.8 | 33.6 | 32.0 | 35.8 | 37.2 | 29.6 | 26.6 | 19.5 | 19.2 | 17.3 | 20.5 |
| Current Assets | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 20.4 | 21.3 | 27.3 | 31.0 | 24.3 | 28.5 | 28.2 | 28.2 | 35.6 | 32.4 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 20.4 | 21.3 | 27.3 | 31.0 | 24.3 | 28.5 | 28.2 | 28.2 | 35.6 | 32.4 | |
| Accounts Receivable | 40.1 | 39.1 | 42.0 | 38.6 | 40.2 | 35.6 | 39.1 | 36.0 | 36.3 | 35.6 | |
| Inventory | 27.7 | 28.1 | 25.4 | 28.1 | 29.7 | 31.8 | 32.7 | 36.0 | 32.9 | 35.6 | |
| Other Current Assets | 9.2 | 9.8 | 8.0 | 13.1 | 13.7 | 10.9 | 9.4 | 18.1 | 12.8 | 11.3 | |
| Total Current Assets | 97.4 | 98.3 | 102.7 | 110.8 | 108.0 | 106.7 | 109.4 | 118.4 | 117.7 | 114.8 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 41.4 | 32.3 | 41.4 | 28.1 | 28.6 | 22.0 | 22.1 | 22.2 | 23.6 | 26.0 | 16.6 | 9.6 | 7.7 | 7.4 | 7.0 | 7.3 | 4.2 | |
| Goodwill | 180.1 | 181.8 | 180.1 | 286.4 | 291.2 | 160.8 | 141.5 | 66.4 | 65.5 | 72.2 | 66.1 | 44.9 | 37.9 | 23.6 | 14.5 | 14.5 | 6.3 | |
| Intangible Assets | 113.8 | 96.9 | 113.8 | 18.2 | 250.1 | 111.7 | 119.9 | 33.2 | 42.9 | 37.8 | 40.8 | 33.2 | 25.4 | 15.4 | 9.8 | 11.5 | 2.7 | |
| Long-Term Investments | 113.8 | 0.0 | 0.0 | 0.0 | 0.0 | -273.2 | -272.9 | -0.2 | -108.5 | -113.5 | -108.2 | -79.8 | -65.2 | -39.9 | -0.7 | 0.0 | -384.9 | |
| Other Long-Term Assets | -112.9 | 18.3 | 0.9 | 209.0 | 11.8 | 275.1 | 275.3 | 0.2 | 108.5 | 109.9 | 106.9 | 78.1 | 63.3 | 39.1 | 0.2 | 0.1 | 8.9 | |
| Total Long-Term Assets | 337.4 | 330.7 | 337.4 | 542.9 | 583.1 | 297.1 | 297.4 | 123.1 | 132.1 | 135.9 | 123.6 | 87.7 | 71.0 | 46.5 | 31.5 | 33.7 | 13.2 | |
| Total Assets | 446.8 | 433.3 | 446.8 | 661.8 | 707.4 | 600.2 | 420.2 | 156.8 | 164.1 | 171.7 | 160.7 | 117.3 | 97.5 | 65.9 | 50.7 | 51.0 | 33.6 |
| Long-Term Assets | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 31.8 | 31.7 | 32.3 | 31.6 | 32.1 | 31.4 | 31.8 | 31.8 | 28.6 | 28.0 | |
| Goodwill | 188.5 | 188.1 | 181.8 | 177.2 | 183.8 | 179.7 | 180.1 | 346.2 | 283.3 | 283.8 | |
| Intangible Assets | 22.8 | 97.4 | 96.9 | 98.2 | 26.9 | 109.5 | 113.8 | 232.8 | 197.7 | 205.4 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 88.4 | 18.9 | 18.3 | 18.1 | 102.1 | 11.8 | 10.5 | 11.6 | 9.0 | 9.6 | |
| Total Long-Term Assets | 332.9 | 337.5 | 330.7 | 326.3 | 346.1 | 333.7 | 337.4 | 623.4 | 519.5 | 527.8 | |
| Total Assets | 430.4 | 435.7 | 433.3 | 437.1 | 454.1 | 440.4 | 446.8 | 741.8 | 637.2 | 642.6 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.0 | 5.7 | 6.0 | 6.1 | 7.9 | 4.5 | 3.4 | 2.9 | 2.4 | 2.2 | 2.8 | 2.5 | 2.0 | 1.0 | 0.6 | 0.7 | 0.5 | |
| Short-Term Debt | 3.0 | 104.6 | 3.0 | 8.0 | 2.8 | 1.0 | 1.1 | 2.1 | 1.6 | 1.1 | 3.0 | 3.0 | 0.0 | 0.0 | 0.0 | 5.0 | 0.0 | |
| Other Current Liabilities | 19.8 | 28.3 | 18.2 | 11.0 | 22.8 | 18.3 | 14.7 | 14.7 | 9.4 | 9.2 | 15.1 | 7.8 | 6.3 | 3.7 | 3.7 | 0.6 | 2.0 | |
| Current Liabilities | 44.3 | 164.0 | 44.3 | 43.4 | 48.1 | 32.6 | 26.0 | 23.7 | 17.3 | 16.6 | 24.0 | 14.7 | 10.2 | 4.7 | 4.3 | 9.9 | 2.4 |
| Current Liabilities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.1 | 6.3 | 5.7 | 4.1 | 6.0 | 5.7 | 6.0 | 4.6 | 4.8 | 5.6 | |
| Short-Term Debt | 4.7 | 105.4 | 104.6 | 104.4 | 104.3 | 6.7 | 3.0 | 3.1 | 2.8 | 2.8 | |
| Other Current Liabilities | 24.3 | 11.0 | 28.3 | 23.9 | 19.2 | 18.8 | 10.7 | 11.6 | 9.6 | 7.5 | |
| Current Liabilities | 48.3 | 149.5 | 164.0 | 155.9 | 153.2 | 54.9 | 44.3 | 44.2 | 39.8 | 39.1 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 221.7 | 76.9 | 228.3 | 183.3 | 218.4 | 145.7 | 140.3 | 20.6 | 44.6 | 53.7 | 42.3 | 23.3 | 16.5 | 4.0 | 0.0 | 1.5 | 0.0 | |
| Capital Leases | 6.6 | 3.5 | 3.0 | 2.9 | 2.8 | 1.0 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 19.8 | 20.2 | 19.8 | 34.0 | 39.2 | 16.3 | 32.5 | 1.1 | 2.6 | 3.6 | 5.4 | 5.1 | 4.9 | 2.4 | 2.5 | 3.1 | 0.5 | |
| Total Liabilities | 301.4 | 273.5 | 301.4 | 268.4 | 313.6 | 193.9 | 200.2 | 45.5 | 64.7 | 73.9 | 76.1 | 43.8 | 33.2 | 13.2 | 6.8 | 14.6 | 2.4 |
| Long-Term Liabilities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 106.0 | 92.2 | 76.9 | 107.2 | 118.6 | 214.8 | 221.7 | 233.0 | 170.7 | 175.5 | |
| Capital Leases | 0.0 | 16.4 | 3.5 | 15.9 | 17.9 | 9.2 | 3.0 | 3.1 | 2.8 | 2.8 | |
| Def. Tax Liability | 21.7 | 21.6 | 20.2 | 18.8 | 20.6 | 19.7 | 19.8 | 44.3 | 33.4 | 33.5 | |
| Total Liabilities | 251.9 | 263.2 | 273.5 | 281.9 | 292.6 | 289.6 | 301.4 | 338.8 | 249.4 | 254.9 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 343.6 | 358.5 | 343.6 | 332.1 | 313.5 | 317.7 | 158.0 | 39.8 | 30.5 | 25.9 | 21.0 | 17.8 | 15.8 | 10.7 | 6.7 | 0.0 | 0.0 | |
| Retained Earnings | -183.5 | -188.9 | -183.5 | 74.2 | 76.7 | 72.5 | 71.9 | 73.3 | 68.3 | 73.7 | 64.8 | 56.0 | 48.6 | 42.2 | 37.6 | 31.3 | 26.3 | |
| Comprehensive Income | -14.8 | -9.8 | -14.8 | -12.8 | 3.7 | 16.1 | -9.9 | -1.8 | 0.6 | -1.8 | -1.2 | -0.2 | -5.8 | -5.2 | -4.4 | -3.7 | -3.0 | |
| Total Common Equity | 145.4 | 159.8 | 145.4 | 393.5 | 393.8 | 406.2 | 220.0 | 111.3 | 99.4 | 97.8 | 84.7 | 73.5 | 64.3 | 52.8 | 43.9 | 36.4 | 31.2 |
| Total Common Equity | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 365.2 | 361.4 | 358.5 | 352.8 | 349.5 | 346.0 | 343.6 | 340.9 | 337.9 | 334.4 | |
| Retained Earnings | -183.5 | -185.1 | -188.9 | -181.0 | -178.4 | -181.0 | -183.5 | 72.0 | 70.7 | 72.8 | |
| Comprehensive Income | -3.2 | -3.8 | -9.8 | -16.6 | -9.7 | -14.3 | -14.8 | -9.8 | -20.8 | -19.5 | |
| Total Common Equity | 178.5 | 172.5 | 159.8 | 155.2 | 161.5 | 150.7 | 145.4 | 403.0 | 387.8 | 387.7 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 231.3 | 181.5 | 231.3 | 170.3 | 221.1 | 146.7 | 141.4 | 22.7 | 46.3 | 54.8 | 45.3 | 26.3 | 16.5 | 4.0 | 0.0 | 6.5 | 0.0 | |
| Book Value | 145.4 | 159.8 | 145.4 | 393.5 | 393.8 | 406.2 | 220.0 | 111.3 | 99.4 | 97.8 | 84.7 | 73.5 | 64.3 | 52.8 | 43.9 | 36.4 | 31.2 |
| Other | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 178.5 | 172.5 | 159.8 | 155.2 | 161.5 | 150.7 | 145.4 | 403.0 | 387.8 | 387.7 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -254.2 | -2.0 | -254.2 | 0.9 | 1.9 | 3.3 | 1.3 | 7.5 | -3.0 | 11.2 | 11.2 | 9.6 | 9.0 | 8.5 | 7.9 | 6.2 | 4.8 | |
| Depreciation & Amortization | 31.6 | 24.5 | 31.6 | 33.8 | 25.1 | 17.7 | 13.0 | 9.4 | 9.5 | 8.7 | 7.2 | 5.7 | 3.8 | 3.4 | 2.2 | 1.8 | 0.8 | |
| Stock-Based Compensation | 11.9 | 13.1 | 11.9 | 12.5 | 11.4 | 9.3 | 5.5 | 4.2 | 1.7 | 1.4 | 1.3 | 1.0 | 0.8 | 1.1 | 0.5 | 0.4 | 0.3 | |
| Change Working Capital | 6.0 | 6.9 | 6.0 | -17.1 | -7.2 | 5.3 | -3.1 | 7.9 | 3.2 | -13.0 | -2.0 | -5.7 | -0.8 | -1.3 | 1.8 | 0.9 | 0.1 | |
| Change In Accounts Receivable | 4.9 | -2.9 | 4.9 | -2.1 | -6.8 | -0.6 | -1.7 | 1.6 | 0.7 | 1.0 | -2.0 | -2.3 | 0.7 | -1.5 | 0.5 | -1.0 | -43.0 | |
| Change In Accounts Payable | -0.1 | -0.4 | -0.1 | -1.5 | 1.4 | 1.0 | -0.1 | 1.1 | 0.2 | -0.7 | -0.2 | 0.4 | 0.8 | 0.4 | -0.2 | 0.0 | 0.2 | |
| Change In Inventories | 2.6 | 1.2 | 2.6 | -10.2 | -1.0 | 0.9 | 0.4 | 2.6 | 2.3 | 0.3 | -1.2 | -3.2 | -1.3 | -0.2 | 1.3 | -0.1 | -0.1 | |
| Other Non-cash Items | 296.8 | 4.3 | 277.3 | 1.3 | 8.0 | 5.1 | 11.8 | 4.0 | 16.1 | 0.1 | 0.1 | -0.2 | -0.4 | 0.0 | 0.4 | 0.0 | -0.1 | |
| Cash from Operations | 44.1 | 0.0 | 0.0 | 28.0 | 39.2 | 37.1 | 26.6 | 30.6 | 24.8 | 7.8 | 16.9 | 10.8 | 12.4 | 11.4 | 12.5 | 8.9 | 6.0 |
| Cash Flow From Operating Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 3.6 | 2.5 | 4.7 | -7.1 | -1.7 | 3.4 | 3.4 | -254.6 | 2.1 | -1.2 | |
| Depreciation & Amortization | 5.7 | 5.8 | 6.0 | 7.5 | 5.5 | 6.1 | 5.5 | 6.3 | 9.0 | 8.1 | |
| Stock-Based Compensation | 3.4 | 3.8 | 3.9 | 3.1 | 3.2 | 3.8 | 2.9 | 2.8 | 0.0 | 0.0 | |
| Change Working Capital | 10.0 | -5.4 | -8.0 | 9.7 | 3.6 | 0.3 | -0.3 | 8.6 | -0.1 | -1.4 | |
| Change In Accounts Receivable | -0.8 | -1.7 | 3.4 | -3.0 | 0.7 | -4.0 | 3.5 | -3.4 | 2.8 | -1.0 | |
| Change In Accounts Payable | 0.1 | -1.2 | 0.2 | 1.5 | -1.7 | 0.2 | -0.4 | 1.6 | -0.3 | -0.8 | |
| Change In Inventories | 0.6 | -0.8 | -3.3 | 1.7 | -0.5 | 0.6 | -0.7 | 2.3 | 0.4 | 1.1 | |
| Other Non-cash Items | -4.0 | 1.5 | -4.7 | -0.5 | 7.8 | -8.4 | -1.0 | 249.8 | 0.5 | 4.3 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -2.6 | -4.2 | -2.6 | -4.5 | -4.4 | -2.0 | -1.5 | -1.3 | -2.8 | -11.6 | -7.7 | -2.8 | -1.0 | -0.9 | -0.7 | -2.6 | -3.2 | |
| Acquisitions | -78.7 | 0.0 | -78.7 | -5.0 | -300.8 | 0.0 | -184.1 | -4.8 | -15.5 | -6.8 | -24.1 | -20.5 | -22.8 | -16.7 | -0.7 | -18.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | -9.5 | 0.0 | 0.0 | 0.0 | 2.2 | 1.1 | 0.0 | 0.0 | 0.0 | 0.7 | 0.0 | 0.0 | -0.1 | 0.0 | |
| Cash from Investing | -81.3 | 0.0 | 0.0 | -9.5 | -305.2 | -2.0 | -185.6 | -3.9 | -17.2 | -18.4 | -31.8 | -23.4 | -23.1 | -17.6 | -1.4 | -20.7 | -3.2 |
| Cash Flow From Investing Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.7 | -1.1 | -1.0 | -0.8 | -0.8 | -1.8 | -0.9 | -0.5 | -1.1 | -0.6 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | -79.7 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -33.5 | 0.0 | 0.0 | -36.0 | -21.0 | 0.0 | -23.0 | -25.6 | -19.6 | -57.0 | -6.0 | -13.3 | -8.5 | -7.0 | 0.0 | -0.8 | 0.0 | |
| Debt Issued | 78.7 | -49.8 | 61.0 | -14.9 | 95.4 | 5.3 | 141.6 | 2.1 | 11.1 | 66.6 | 25.0 | 23.0 | 21.0 | 11.0 | -6.5 | 7.3 | 0.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 7.0 | 0.0 | 145.9 | 85.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.2 | 0.1 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | -0.9 | 0.0 | 0.0 | 177.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | -0.3 | |
| Dividends Paid | -3.4 | 0.0 | 0.0 | -3.4 | -3.3 | -3.2 | -2.7 | -2.5 | -2.4 | -2.4 | -2.3 | -2.2 | -2.0 | -1.8 | -1.6 | -1.5 | -1.3 | |
| Other Financing Activities | 69.4 | 0.0 | 0.0 | -0.9 | 76.9 | 3.5 | -5.4 | 6.4 | 13.9 | 70.1 | 26.9 | 24.5 | 22.8 | 11.9 | -5.7 | 0.1 | 0.1 | |
| Cash from Financing | 32.8 | 0.0 | 0.0 | -33.3 | 52.6 | 146.2 | 231.3 | -21.7 | -8.1 | 10.7 | 18.6 | 9.1 | 12.3 | 3.0 | -7.4 | 4.9 | -1.5 |
| Cash Flow From Financing Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 110.7 | -86.9 | 16.1 | -30.1 | -11.2 | 1.4 | -3.2 | -11.4 | 62.6 | -4.8 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -4.7 | -0.9 | -4.7 | -16.4 | -214.5 | 182.5 | 71.2 | 4.7 | -0.4 | 0.1 | 3.7 | -3.5 | 1.6 | -3.2 | 3.6 | -6.9 | 1.4 | |
| Closing Cash Balance | 28.2 | 27.3 | 28.2 | 32.9 | 49.3 | 263.9 | 81.4 | 10.2 | 5.5 | 5.8 | 5.7 | 2.0 | 5.6 | 4.0 | 7.2 | 3.5 | 10.5 |
| Cash position | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 8.6 | -0.9 | -6.0 | -3.6 | 6.6 | -4.1 | 0.3 | 0.0 | -7.4 | 3.2 | |
| Closing Cash Balance | 29.0 | 20.4 | 21.3 | 27.3 | 31.0 | 24.3 | 28.5 | 28.2 | 28.2 | 35.6 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 41.6 | 42.3 | 41.6 | 23.4 | 34.8 | 35.1 | 25.1 | 29.3 | 22.0 | -3.9 | 9.2 | 8.0 | 11.3 | 10.5 | 11.8 | 6.2 | 2.8 | |
| Real Free Cash Flow | 29.6 | 29.2 | 29.6 | 10.9 | 23.4 | 25.8 | 19.5 | 25.1 | 20.3 | -5.3 | 7.8 | 7.0 | 10.5 | 9.4 | 11.3 | 5.8 | 2.5 |
| Free Cash Flow | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 18.0 | 7.1 | 0.9 | 11.7 | 17.6 | 3.5 | 9.5 | 12.3 | 10.4 | 9.1 | |
| Real Free Cash Flow | 14.6 | 3.3 | -3.0 | 8.5 | 14.4 | -0.4 | 6.6 | 9.6 | 10.4 | 9.1 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 132 | -48.3 | 1575.5 |
| P/S | 2 | 5.5 | 188 |
| P/B | 2.8 | 4.2 | 316.8 |
| P/FCF | 21 | 33.8 | 11192.4 |
| Market cap | $0.4 | $0.6 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 22.4 % | 0 % |
| Debt to Income | 2964.3 % | -698.5 % | 0 % |
| Debt to Free cash flow | 471.4 % | 55.2 % | 0 % |
| Interest expense percentage | 61.6 % | 12.7 % | 61.6 % |
| Current ratio | 2 | 4 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 2.1 % | -2.5 % | 0 % |
| ROA | 0.9 % | 1.9 % | 0 % |
| CapEx to Revenue | 1.5 % | 3.3 % | 33.2 % |
| RaD to Revenue | 0 % | 5.2 % | 0 % |
| ROEM | 339,097.3 | 222562.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 60.6 % | 59.7 % | 83 % |
| Operating margin | 7 % | 15.6 % | 50.9 % |
| Net margin | 1.5 % | 2.4 % | 37.4 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.6 % | 0 % |
| Dividend payout percentage | 0 % | -2.7 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 5.6 mil | 4.2 mil |
| Employee count | 0.7 tis | 0.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
